Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology

Neurological Research
D H Rhoney, D Parker

Abstract

Sedation and analgesia is used primarily in the intensive care unit (ICU) to limit the stress response to critical illness, provide anxiolysis, improve ventilatory support, and facilitate adequate ICU care. However, in the neurotrauma ICU there are many other reasons for the use of these agents. The primary aim is to prevent secondary cerebral damage by maintaining adequate cerebral perfusion pressures. This is accomplished in several different ways. Controlling intracranial pressure (ICP) and maintaining an adequate mean arterial pressure (MAP) is at the cornerstone of this management. Lowering the metabolic demands of the brain is also an important consideration as a treatment strategy. Analgesic and sedative agents are utilized to prevent undesirable increases in ICP and to lower cerebral metabolic demands. Concerns surrounding the use of these agents include time to awakening after discontinuation, effect on the cerebrovasculature, and the effect on patient outcome. There are many different pharmacological agents available, each with their distinct advantages and disadvantages. The purpose of this review is to evaluate the pharmacokinetic and pharmacological effects of each of these agents when used in neurotrauma patients.

References

Oct 1, 1978·Clinical Pharmacology and Therapeutics·J W KrausG R Wilkinson
Apr 1, 1979·British Journal of Anaesthesia·E MossD G McDowall
Jul 1, 1977·Anesthesia and Analgesia·M M Ghoneim, T Yamada
Oct 1, 1978·British Journal of Anaesthesia·A M RenouJ M Caillé
Feb 1, 1975·Anesthesiology·P F WhiteC R Pudwill
May 22, 1975·The New England Journal of Medicine·J V WeilI E Sodal
Jul 1, 1975·Canadian Anaesthetists' Society Journal·M G SolimanG Kuster
Sep 1, 1992·British Journal of Anaesthesia·C Frenkel, B W Urban
Jun 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·J W Flacke
Aug 1, 1992·Anesthesia and Analgesia·M H ZornowM Matsumoto
Dec 1, 1992·Anesthesia and Analgesia·W A KofkeR A Hawkins
Mar 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P A Modica, R Tempelhoff
Apr 1, 1992·Critical Care Medicine·A Kumar, T P Bleck
Apr 1, 1992·Biological Psychiatry·R J MathewK E Wiethe
Jul 1, 1991·British Journal of Anaesthesia·B MarshG N Kenny
Nov 1, 1991·Clinical Pharmacology and Therapeutics·B A BoucherJ T Robertson
Nov 1, 1990·Anesthesiology·P L BaileyT H Stanley
Feb 1, 1990·Anesthesia and Analgesia·L N MildeW J Gallagher
Nov 1, 1990·Anaesthesia·C R Chilvers, P S Laurie
Dec 1, 1990·British Journal of Anaesthesia·S S GillC S Reilly
Jan 1, 1990·European Journal of Clinical Pharmacology·T AnderssonP Lundborg
Mar 1, 1990·British Journal of Clinical Pharmacology·J HasselströmJ Säwe
Nov 1, 1989·Therapeutic Drug Monitoring·D J GreenblattR I Shader

❮ Previous
Next ❯

Citations

Jan 5, 2008·Current Treatment Options in Neurology·Sebastian Schulz-Stübner
Aug 2, 2007·The American Journal of Nursing·Brenda T Pun, Jan Dunn
Oct 11, 2012·Emergency Medicine International·Oliver Flower, Simon Hellings
Apr 21, 2010·Critical Care : the Official Journal of the Critical Care Forum·Ingrid EgerodKaren-Lise Welling
Nov 15, 2006·Journal of Clinical Monitoring and Computing·Leslie C Jameson, Tod B Sloan
May 11, 2012·Revue neurologique·K VahediUNKNOWN French Society of Intensive Care
Jul 7, 2009·Critical Care Clinics·Heidi A B SmithE Wesley Ely
Mar 11, 2006·Journal of Neuroradiology. Journal De Neuroradiologie·M WintermarkP Schnyder
May 27, 2006·Critical Care Nursing Clinics of North America·Richard Arbour
Aug 5, 2003·British Journal of Clinical Pharmacology·Per-Henrik ZingmarkE Niclas Jonsson
May 9, 2008·Acta Neurologica Scandinavica·P RønningE Helseth
May 26, 2004·Annales Françaises D'anesthèsie Et De Rèanimation·R L Chioléro, P Schoettker
Apr 6, 2004·The Veterinary Clinics of North America. Equine Practice·Robert J MacKay
Jun 21, 2002·Neurological Research·Jacqueline J KrausWilliam M Coplin
Mar 23, 2006·Neurological Research·Judith Sonn, Avraham Mayevsky
Sep 26, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mathieu DehaesP Ellen Grant
Mar 15, 2006·Medicinski Arhiv·Amira DurićSelma Vanis-Vatrenjak
Jan 14, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Susan C Urwin, David K Menon
Dec 31, 2002·Anesthesia and Analgesia·Kai-Michael ScheuflerJosef Zentner
Oct 5, 2006·Current Opinion in Anaesthesiology·S Himmelseher, E Pfenninger
Mar 27, 2003·Current Opinion in Critical Care·Giuseppe Citerio, Manuela Cormio
Jan 30, 2015·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Richard B Arbour, Jonathan Dissin
Nov 5, 2005·AACN Clinical Issues·Linda Littlejohns, Mary Kay Bader
Dec 15, 2020·Journal of Cardiothoracic and Vascular Anesthesia·Jason Z QuAdam A Dalia
Apr 9, 2021·Frontiers in Neurology·Shane Musick, Anthony Alberico

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.